Seeking Alpha

Mylan (MYL +4.1%) jumps after receiving final FDA approval of its Abbreviated New Drug...

Mylan (MYL +4.1%) jumps after receiving final FDA approval of its Abbreviated New Drug Application for its chemoprotective agent Dexrazoxane for injection, a generic version of Pharmacia & Upjohn's Zinecard.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)